Results From A Phase Iia Study Of The Anti-Cxcl12 Spiegelmer Olaptesed Pegol (Nox-A12) In Combination With Bendamustine/Rituximab In Patients With Chronic Lymphocytic Leukemia
HAEMATOLOGICA（2014）
摘要
Background
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要